Mao Miyamoto Medical Media

What Mao Miyamoto Medical Media does

Mao Miyamoto Medical Media, operating as M4, is a private, founder-owned boutique creative agency founded in 2017 by Mao Miyamoto, a former biologist, and headquartered at 125 Mt. Auburn St, Cambridge, Massachusetts. The firm provides corporate communications, branding, and visual storytelling services to life sciences clients — spanning major pharmaceutical companies, biotech startups from Series A through commercialization, academic medical centers, professional medical societies, and hospitals. Its central proposition is the construction of integrated communication systems rather than isolated creative deliverables, with a recurring emphasis on translating complex scientific data into compelling, accurate narratives for investors, physicians, patients, and the public.

The company's work is organized into three integrated service lines — Systems Design (Communication Readiness Assessment, brand systems, positioning, messaging, channel planning, GTM launch preparation), Scalable Assets (pitch decks, websites, MoA/MoD animations, scientific figures, brand libraries, conference materials), and Structured Execution (channel activation, conference strategy, thought-leadership campaigns, KPI reviews). Production is grounded in a stack of mainstream creative tools — Photoshop, Illustrator, Cinema 4D, Zbrush, 3D Studio Max, After Effects, InDesign, HTML5, PHP, CSS3 — with scientific accuracy supported by primary literature, Protein Data Bank references, and Visual Molecular Dynamics. Programs such as Visionary Crossings (a 2025 partnership with LabCentral installing a 32-piece 3D art series at Gallery 1832) extend the offering into branded experiential work.

M4 engages clients on retainer-based, embedded partnerships — functioning in practice as a fractional communications/CMO function — and supplements this with project-based creative services. The team is lean, comprising approximately six named professionals (founder/CEO, PhD strategist/PM, Certified Medical Illustrator, sales associate, and additional team members). The disclosed client roster includes Abbott, AstraZeneca, Boehringer Ingelheim, GE, GSK, Johnson & Johnson, Emory University, Harvard Medical School, MIT, Mayo Clinic, Northwestern University, Stanford, and Tufts, alongside newer startup clients such as Stingthera and SpaceXyme. Pricing is not publicly disclosed; the company has no outside institutional investors, no M&A activity, and no disclosed funding.

Name

Mao Miyamoto Medical Media

Legal name

Mao Miyamoto Medical Media, Inc.

Website

https://maomiyamoto.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Mao Miyamoto Medical Media (M4) is a Cambridge-based boutique creative agency providing branding and integrated communication systems for life sciences clients — including major pharma, biotech, and academic institutions — through retainer-based strategic partnerships led by a science-trained team.

Ownership category

akta.pro rank

Product category

Life Sciences Marketing & Communications Services

NAICS

Advertising, Public Relations, and Related Services (5418)

SIC

Services-Advertising (7310)

akta.pro primary industry

Healthcare/Pharma Creative Agencies (MPAAAAAJ)

Keywords

• Life sciences marketing
• Medical communications agency
• Scientific storytelling services
• Biotech branding agency
• Pharmaceutical content production

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Strategic Communication Retainer Services: M4 operates on a retainer-based engagement model where they work as an embedded strategic partner alongside clients over extended periods. This provides recurring retainer revenue and allows them to build integrated communication systems rather than delivering one-off assets.
2. Project-Based Creative Services: Bespoke creative deliverables including pitch decks, websites, animations, scientific figures, brand identity, conference materials, and campaign assets. Primarily structured within long-term retainer frameworks rather than standalone hourly or fixed-fee engagements.
3. Consulting and Advisory: Fractional CMO / communication strategist services including communication readiness assessments, brand strategy, positioning and messaging, channel planning, and go-to-market launch preparation.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Mao Miyamoto Medical Media (M4) is a full-service creative agency for the life sciences industry that delivers integrated corporate communication solutions across three service lines: Systems Design (strategic consulting including Communication Readiness Assessment, brand systems, positioning, messaging, and go-to-market launch prep); Scalable Assets (visual content production such as pitch decks, scientific communications, websites, MoA/MoD animations, brand libraries, and conference materials); and Structured Execution (campaign activation, conference support, thought leadership campaigns, and integrated go-to-market implementation). Services are delivered primarily through retainer-based engagements that position M4 as an embedded strategic partner to biotech, pharmaceutical, healthcare, and academic clients.

Product overview

M4 (Mao Miyamoto Medical Media) operates as a full-service marketing and branding agency for the life sciences industry, offering integrated corporate communication solutions organized into three core service lines. Systems Design provides strategic consulting and communication infrastructure planning; Scalable Assets produces visual content, presentations, websites, and multimedia materials; and Structured Execution handles campaign activation, conference support, and go-to-market implementation. Visionary Crossings is a distinct community-building art program that transforms biotech spaces through science-inspired installations. The three service lines function as an integrated system: strategic planning feeds into asset creation, which enables structured execution across channels.

Differentiator

Problem solved

Functional benefit

Products and services

• Systems Design Strategic consulting offering that includes Communication Readiness Assessment, Materials Review, Market Gap & Implementation Roadmap, Brand Systems Establishment, Positioning & Messaging, Channel Planning, Campaign Design, US Localization, and Go-to-Market Launch Prep, designed for life science companies needing integrated communication infrastructure.
• Scalable Assets Content creation and asset production offering including Pitch Deck & 1-Pager, Scientific Communications Support, Campaign Templates & Social Kits, Website Design & Development, Investment & Partner Packs, Brand & Messaging Libraries, Presentations & Core Slide Library, MoA/MoD Videos, KOL Interviews, and Conference Materials.
• Structured Execution Campaign activation and execution offering including Channel Activation Support, Conference Strategy & Support, Event & Sponsorship, Thought Leadership Campaign, Integrated Go-to-Market, Email Flows Implementation, Advisory Support & KPI Reviews, and Internal Communication Support.
• Visionary Crossings A creative program that transforms everyday spaces into catalysts for authentic connection by integrating science-inspired art installations into biotech environments to foster curiosity, conversation, and community among scientists, entrepreneurs, sponsors, and visitors.

Quantifiable outcome

• Reached frontline healthcare providers from the Philippines to Colorado, from Puerto Rico to US military bases, helping reduce COVID-19 infections and deaths during the pandemic.
• +3 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• LabCentralcoreStrategic or Co-development Partner · 1 October 2025M4 partnered with LabCentral, a leading biotech incubator in Boston's Kendall Square, for the Visionary Crossings initiative — a 32-piece 3D art installation at Gallery 1832. The project fostered community and authentic connection among biotech innovators, sponsors, and visitors. The opening reception drew 200+ attendees and all artworks sold before the event officially began.
• AstraZenecaminorStrategic or Co-development Partner · 1 April 2021AstraZeneca was one of the pharmaceutical sponsors of the CHEST Foundation Asthma Guide project alongside Sanofi, GSK, and Regeneron. The project was a collaborative educational initiative to create a web and print asthma guide for patients and physicians.
• SanofiminorStrategic or Co-development Partner · 1 April 2021Sanofi co-sponsored the CHEST Foundation Asthma Guide project alongside AstraZeneca, GSK, and Regeneron, to improve patient education for severe asthma patients.
• GlaxoSmithKline (GSK)minorStrategic or Co-development Partner · 1 April 2021GSK co-sponsored the CHEST Foundation Asthma Guide project alongside AstraZeneca, Sanofi, and Regeneron, to fund development of accessible asthma patient education materials.
• RegeneronminorStrategic or Co-development Partner · 1 April 2021Regeneron co-sponsored the CHEST Foundation Asthma Guide project alongside AstraZeneca, Sanofi, and GSK, to create an e-learning asthma library and printable guide.
• CHEST FoundationcoreStrategic or Co-development Partner · 1 April 2021M4 partnered with the CHEST Foundation to create an asthma e-learning library and printable guidebook. M4 provided content strategy, communication design, motion graphics, 2D/3D animation, and UX design. The project ran April–September 2021 and achieved measurable outcomes including reduced hospital visits for severe asthma patients.
• Stingthera, Inc.minorStrategic or Co-development Partner · 1 April 2021M4 partnered with Stingthera, Inc., a pharmaceutical company focusing on biophysics of therapeutic targets, to create a new logo representing their target protein heterodimer with an elegant butterfly motif and custom typography.
• Emory University (Serious Communicable Diseases Program)coreStrategic or Co-development Partner · 1 April 2020M4 partnered with Emory University's SCDP during the COVID-19 pandemic to develop standardized PPE reuse protocols, printable instructions, videos, and an interactive app. The collaboration addressed the global PPE shortage and reached frontline healthcare workers worldwide from April 2020 to February 2021.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Random42 Scientific Communication: Scientific animation and medical communications studio producing MoA/MoD animations, scientific narratives, and congress content for global pharma — same core offering as M4 with a more global client base.
• Giant Creative Strategy: Independent healthcare agency providing strategy, creative, and content for biotech, pharma, and medical device brands — directly comparable mid-sized player in life sciences marketing.
• Nucleus Medical Media: Medical illustration and 3D animation studio producing medical content for publishers, pharma, and healthcare organizations — closely comparable in scientific illustration and patient/physician education deliverables.
• Concentric Health Experience: Specialist healthcare agency focused on patient, HCP, and payer communications for pharma — competes with M4 for commercialization-stage pharma marketing budgets.
• Cognition Studio: Boutique scientific visualization and medical animation studio producing 3D molecular, medical device, and mechanism-of-action storytelling for biotech and pharma — directly comparable in size, offerings, and target buyer as M4.
• HCB Health: Independent healthcare and pharma creative agency offering brand strategy, creative, and digital activation for life sciences clients — competing for similar buyer budgets at biotech and pharma clients.
• Bliss Health: Healthcare and pharma marketing agency offering digital, creative, and communications services to life science clients — comparable niche-specialized agency competing for similar biotech/pharma mandates.

Broad incumbents

• Havas Health & You: Global healthcare and wellness communications network under Havas — competes for the same pharma and biotech brand budgets with significantly greater scale, geographic reach, and integrated services.
• Intouch Solutions: Large full-service healthcare marketing agency (now part of Avalanche) serving pharma and biotech across brand, medical, and digital — broader portfolio but overlapping on biotech brand strategy and creative execution.
• CDM (now CDM New York / Omnicom): Healthcare-focused creative agency within Omnicom's health network, producing brand, digital, and content for pharma — broader portfolio and scale than M4 with overlapping HCP and patient communications work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/mao-miyamoto-medical-media-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mao Miyamoto Medical Media